×
Atossa Genetics Total Long-Term Assets 2012-2024 | ATOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Atossa Genetics total long-term assets from 2012 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
View More
Atossa Genetics Total Long-Term Assets 2012-2024 | ATOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Atossa Genetics total long-term assets from 2012 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$216B
Thermo Fisher Scientific (TMO)
$205.7B
Alcon (ALC)
$44.2B
Edwards Lifesciences (EW)
$44.1B
IDEXX Laboratories (IDXX)
$37.1B
DexCom (DXCM)
$34.9B
IQVIA Holdings (IQV)
$34.2B
Mettler-Toledo (MTD)
$27.3B
Waters (WAT)
$22.6B
STERIS (STE)
$21.7B
SONOVA HOLDING (SONVY)
$19.3B
Hologic (HOLX)
$14.4B
Fresenius Medical Care AG KGaA (FMS)
$13.5B
Penumbra (PEN)
$11.7B
Sysmex ADR (SSMXY)
$11.5B
Globus Medical (GMED)
$11.5B
Masimo (MASI)
$9.5B
Glaukos (GKOS)
$8.7B
Teleflex (TFX)
$8.1B
Inari Medical (NARI)
$4.7B
Integer Holdings (ITGR)
$4.5B
PROCEPT BioRobotics (PRCT)
$3.4B
Veracyte (VCYT)
$3.2B
Nihon Kohden (NHNKY)
$2.7B
LivaNova (LIVN)
$2.6B
TransMedics (TMDX)
$2.5B
Elekta AB (EKTAY)
$2.3B
Tandem Diabetes Care (TNDM)
$2.1B
Integra LifeSciences Holdings (IART)
$1.7B
Alphatec Holdings (ATEC)
$1.5B